Professional Documents
Culture Documents
Although Kingsford Pharmaceuticals hired the top research scientists, X23 will still need
to be tested and approved by the Food and Drug Administration before the tablet will be made
accessible to the public.
The company however is eager to make the announcement of the remarkable discovery
on Sept. 28, two days prior to their stockholders annual meeting on Sept.30.
CEO of Kingsford Pharmaceuticals Roberta Cruz- Suarez has gone on to say, This
medication is a medical breakthrough that will have profound implications on human health. X23
has the potential to save thousands of lives. We are confident of securing FDA approval quickly
so that we can get X23 into the hands of doctors and nurses all over the world who will partner
with us to fight against the West Nile Virus.